Evidence map›Paper›PMID 24292568›Full record

ReviewIn vivo (Athens, Greece)

Role of cytokines as a double-edged sword in sepsis.

Hina Chaudhry, Juhua Zhou, Yin Zhong, Mir Mustafa Ali, Franklin McGuire, Prakash S Nagarkatti, Mitzi Nagarkatti

2 registry-linked trialsAbstract readReview
In one paragraph

Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 326 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
326citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05467605 nacompletednot on this map

Effect of Probiotics on Interleukin 6 and Transforming Growth Factor-βLevels in Critically Ill Children With Sepsis

TypeinterventionalSponsorCairo UniversityRan2022 to 2023Enrolled80ConditionsSepsis, SevereArmsprobiotics( Lactobacillus acidophilus, lactobacillus delbruekii and lactobacillus fermentum 10 billions),, maltose dissolved in distilled water
NCT07715110 nanot yet recruitingnot on this map

Biological and Immunomodulatory Effect of Hemoadsorption With Macroporous Resin Cartridges in Septic Shock and Refractory Septic Shock Two Parallel Open-label Randomized Pilot Trials.

TypeinterventionalSponsorMiguel Sanchez GarciaRan2027 to 2029Enrolled16ConditionsSeptic Shock, Vasopressor Resistance, Multiple Organ Dysfunction, Sepsis, HemoperfusionArmsHemoadsorption cartridge
3 · Its place in the literature

Who cites it

326 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Comparison of plasma cytokine expression in adult haematological malignancy patients with bacterial and/or fungal infections.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. AnACS omega · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

266 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hina ChaudhryInstitute for Tumor Immunology, Ludong University School of Life Sciences, 186 Hongqi Middle Road, Yantai, Shandong 264025, PR China. Juhua.Zhou@gmail.com.
Juhua Zhou
Yin Zhong
Mir Mustafa Ali
Franklin McGuire
Prakash S Nagarkatti
Mitzi Nagarkatti

Funding

Use of Resveratrol to treat experimental multiple sclerosisP01AT003961 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, PRAKASH S · 2007 to 2018
$14.2M
Role of natural indoles in experimental autoimmune encephalomyelitisR01AT006888 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI · 2011 to 2015
$2.0M
Immunopathological basis of PTSDR01MH094755 · NIMH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, PRAKASH S · 2011 to 2015
$1.7M
Estrogen-T cell InteractionsR01ES019313 · NIEHS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI, NAGARKATTI, PRAKASH S · 2010 to 2014
$1.5M
Role of CD44 in experimental Multiple SclerosisI01BX001357 · VA · VETERANS HEALTH ADMINISTRATION · PI NAGARKATTI, MITZI · 2012 to 2015
–
BLRD VA I01 BX001357NCCIH NIH HHS P01 AT003961NCCIH NIH HHS P01AT003961NCCIH NIH HHS R01 AT006888NCCIH NIH HHS R01AT006888NIEHS NIH HHS R01 ES019313NIEHS NIH HHS R01ES019313NIMH NIH HHS R01 MH094755NIMH NIH HHS R01MH094755
6 · The paper itself

Abstract

backgroundSepsis is a deadly immunological disorder and its pathophysiology is still poorly understood. We aimed to determine if specific pro-inflammatory and anti-inflammatory cytokines can be used as diagnostic and therapeutic targets for sepsis. MATERIALS AND

methodsRecent publications in the MEDLINE database were searched for articles regarding the clinical significance of inflammatory cytokines in sepsis.

resultsIn response to pathogen infection, pro-inflammatory cytokines [interleukin-6 (IL-6), IL-8, IL-18 and tumor necrosis factor-α (TNF-α)] and anti-inflammatory cytokine (IL-10) increased in patients with sepsis. Importantly, a decrease in IL-6 was associated with a better prognosis and overproduction of IL-10 was found to be the main predictor of severity and fatal outcome.

conclusionBoth pro-inflammatory and anti-inflammatory cytokines constitute a double-edged sword in sepsis; on one hand they are critical to eliminate the infection while on the other, excessive production can cause tissue and organ damage. Increase in cytokines such as IL-6, Il-8, IL-10, IL-18 and TNF-α may have implications in diagnosis and treatment of sepsis.

Indexed as

AnimalsBiomarkersCytokinesGenetic Predisposition to DiseaseHumansInflammation MediatorsPolymorphism, Single NucleotideSepsisSignal TransductionBiomarkersCytokinesInflammation Mediatorsanti-inflammatorybiomarkercytokinepro-inflammatoryreviewSepsissignaling pathway

Identifiers

PMID24292568
PMCPMC4378830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.